Mohammedarfat N K., A. (2023). Combination treatment of doxorubicin and SAR405-loaded chitosan nanoparticles for dual targeted anticancer therapy assessment in A549 lung cancer cell line.
Chicago Style (17th ed.) CitationMohammedarfat N K., Alamassi. Combination Treatment of Doxorubicin and SAR405-loaded Chitosan Nanoparticles for Dual Targeted Anticancer Therapy Assessment in A549 Lung Cancer Cell Line. 2023.
MLA引文Mohammedarfat N K., Alamassi. Combination Treatment of Doxorubicin and SAR405-loaded Chitosan Nanoparticles for Dual Targeted Anticancer Therapy Assessment in A549 Lung Cancer Cell Line. 2023.
警告：這些引文格式不一定是100％准確.